Has Inell Rosario, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,740 in general payments to Inell Rosario, MD across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Inell Rosario, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Inell Rosario, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Inell Rosario, MD

Otolaryngology · Inver Grove Heights, MNNPI 1104862523

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.1% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.

$1,740in general payments, 2019–2025

Across 66 payments — averaging $26.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aerin Medical Inc.$358
Stryker$201
Phadia US Inc.$147
Inspire Medical Systems, Inc.$120
Preceptis Medical, Inc.$118
Jazz Pharmaceuticals Inc.$113
plus $682 from 17 others

What the payments were for

Speaking & faculty fees$372%
Travel & lodging$221%
Food & beverage$1,63694%
Education$443%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aerin Medical Inc.	10	$358
Stryker	7	$201
Phadia US Inc.	9	$147
Inspire Medical Systems, Inc.	5	$120
Preceptis Medical, Inc.	1	$118
Jazz Pharmaceuticals Inc.	4	$113
Biolase, Inc.	1	$97
Intersect ENT, Inc.	3	$93
Optinose US, Inc.	6	$80
Harmony Biosciences LLC	2	$43
3b Medical, Inc.	2	$40
Kerecis Limited	1	$38
AbbVie	1	$37
Acera Surgical, Inc.	2	$36
Itamar Medical Inc	2	$33
GSK	2	$31
Philips North America LLC	1	$29
Neurent Medical Limited	1	$28
ZOLL Respicardia, Inc.	1	$25
Phathom Pharmaceuticals, Inc.	2	$25
Avadel CNS Pharmaceuticals, LLC	1	$20
Sanofi	1	$15
Smith+Nephew	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,740 in reported general payments places this provider in the 70th percentile of 181 otolaryngology providers in Minnesota.

See all otolaryngology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$77,014

Medicare patients

195

Services billed

673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	23	$3,233
Azelastine Hcl	136	$2,777
Ipratropium Bromide	62	$1,523
Cefdinir	90	$1,264
Famotidine	47	$585
Fluticasone Propionate	49	$507
Methylprednisolone	35	$232
Doxycycline Hyclate	24	$208
Mupirocin	15	$150
Amoxicillin	26	$97
Azithromycin	18	$85

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Inver Grove Heights

Samuel LevineMinneapolis$151K
George GodingMinneapolis$143K
Theodore TruittSaint Cloud$96K
Matthew CarlsonRochester$80K
Troy HemmeMaple Grove$28K
Michael PaparellaMinneapolis$22K
Oleg FroymovichMinneapolis$20K
David HamlarSt. Paul$19K
Rijul KshirsagarRochester$18K
Brian NeffRochester$16K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →